This content is current only at the time of printing. This document was printed on 21 February 2020. A current copy is located at https://apvma.gov.au/node/20726
You are here
Proposed approval of clodronate disodium tetrahydrate and the registration of Osphos 51 mg/ml Solution for Injection for Horses
This consultation closed on 1 November 2016.
The APVMA is considering an application for the approval of clodronate disodium tetrahydrate and registration of Osphos 51 mg/ml Solution for Injection for Horses. The product is to be used for the improvement of lameness associated with navicular syndrome in horses.
We invite comment from 4 October 2016 to 1 November 2016 on whether the application for approval of the active constituent and/or registration of the product should be granted.
The APVMA is able to consider comments relating to the legislative grounds for registration, including:
- chemistry and manufacture
- safety criteria
- efficacy criteria
- trade criteria.
For more information see page 37 of Gazette No. 20 from 4 October 2016
Please send your written submission by email, post or fax to:
Registration Management and Enquiries
Australian Pesticides and Veterinary Medicines Authority
PO Box 6182
Kingston ACT 2604
Fax: +61 2 6210 4721
Phone: +61 2 6210 4701